McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms (NYSE:MCK)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...